Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioAtla, Inc. Director's Dealing 2020

Dec 16, 2020

34681_dirs_2020-12-15_334cd06c-1e9a-452b-a97a-3f142498559f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2020-12-15

Reporting Person: Levy Guy (Director, 10% Owner)
Reporting Person: Soleus Private Equity GP I, LLC (10% Owner)
Reporting Person: Soleus Private Equity Fund I, L.P. (10% Owner)
Reporting Person: Soleus PE GP I, LLC (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 14871 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series D Preferred Stock $ Common Stock (1790472) Indirect

Footnotes

F1: Includes 14,871 restricted stock units ("RSUs"). 33.3% of the RSUs vest on December 7, 2021, with the remainder vesting in 24 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting dates.

F2: Each share of Series D Preferred Stock is convertible at any time, at the holder's election, into Common Stock, based on the then-applicable conversion rate and has no expiration date.

F3: The shares of Series D Preferred Stock will convert automatically into 1,790,472 shares of Common Stock upon the closing of the Issuer's initial public offering. These amounts reflect a 1-for-13 reverse stock split which became effective on December 2, 2020.

F4: The reportable securities are owned directly by Soleus Private Equity Fund I, L.P. ("Soleus PE"). Soleus Private Equity GP I, LLC ("Soleus GP") is the sole general partner of Soleus PE. Soleus GP holds voting and dispositive power over the shares held by Soleus PE. Soleus PE GP I, LLC ("Soleus PE GP") is the sole manager of Soleus GP. Mr. Guy Levy is the sole managing member of Soleus PE GP. Each of Mr. Guy Levy, Soleus PE GP and Soleus GP disclaims beneficial ownership of these securities and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.